Oshrat Levi-Galibov

846 total citations
7 papers, 255 citations indexed

About

Oshrat Levi-Galibov is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Oshrat Levi-Galibov has authored 7 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Oshrat Levi-Galibov's work include Cancer Cells and Metastasis (4 papers), Heat shock proteins research (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Oshrat Levi-Galibov is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Heat shock proteins research (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Oshrat Levi-Galibov collaborates with scholars based in Israel, United States and Italy. Oshrat Levi-Galibov's co-authors include Ruth Scherz‐Shouval, Yaniv Stein, Shimrit Mayer, Hagar Lavon, Gil Friedman, Meirav Pevsner‐Fischer, Tim J. Cooper, Yuval Shaked, Daphne Weihs and Yifat Ofir‐Birin and has published in prestigious journals such as Nature Communications, Cancer Research and eLife.

In The Last Decade

Oshrat Levi-Galibov

7 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oshrat Levi-Galibov Israel 6 135 122 69 66 38 7 255
Xiangbin Wu China 6 146 1.1× 120 1.0× 105 1.5× 64 1.0× 25 0.7× 9 287
Natascha Santacroce Switzerland 2 139 1.0× 148 1.2× 82 1.2× 33 0.5× 30 0.8× 2 252
Anjali Geethadevi United States 9 190 1.4× 79 0.6× 102 1.5× 45 0.7× 47 1.2× 17 304
Liqiu Liao China 8 252 1.9× 130 1.1× 87 1.3× 70 1.1× 22 0.6× 17 342
Ana I. Oliveira Portugal 11 272 2.0× 109 0.9× 148 2.1× 73 1.1× 35 0.9× 17 415
Shu-Heng Jiang China 3 114 0.8× 61 0.5× 59 0.9× 70 1.1× 25 0.7× 3 214
Ethan J. Brock United States 6 153 1.1× 70 0.6× 67 1.0× 20 0.3× 32 0.8× 6 256
E. Josue Ruiz United Kingdom 8 228 1.7× 122 1.0× 97 1.4× 30 0.5× 58 1.5× 9 325
Tzu-Sheng Hsu Taiwan 9 128 0.9× 86 0.7× 84 1.2× 143 2.2× 24 0.6× 21 314
Erica Dalla United States 4 86 0.6× 109 0.9× 62 0.9× 50 0.8× 19 0.5× 4 186

Countries citing papers authored by Oshrat Levi-Galibov

Since Specialization
Citations

This map shows the geographic impact of Oshrat Levi-Galibov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oshrat Levi-Galibov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oshrat Levi-Galibov more than expected).

Fields of papers citing papers by Oshrat Levi-Galibov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oshrat Levi-Galibov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oshrat Levi-Galibov. The network helps show where Oshrat Levi-Galibov may publish in the future.

Co-authorship network of co-authors of Oshrat Levi-Galibov

This figure shows the co-authorship network connecting the top 25 collaborators of Oshrat Levi-Galibov. A scholar is included among the top collaborators of Oshrat Levi-Galibov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oshrat Levi-Galibov. Oshrat Levi-Galibov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ben‐Shmuel, Aviad, Coral Halperin, Oshrat Levi-Galibov, et al.. (2025). Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer. Cancer Discovery. 15(6). 1247–1269. 12 indexed citations
2.
Cohen, Noam, et al.. (2023). Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche. Cancer Research. 83(20). 3354–3367. 21 indexed citations
3.
Pevsner‐Fischer, Meirav, Tal Goshen‐Lago, Judith Diment, et al.. (2021). Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1–Mediated Secretion of Extracellular Vesicles. Cancer Research. 81(7). 1639–1653. 71 indexed citations
4.
Levi-Galibov, Oshrat, Mahesh Devarasetty, Michael Timaner, et al.. (2021). T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy. Cancer Research. 82(2). 278–291. 55 indexed citations
5.
Shani, Ophir, Yael Raz, Lea Monteran, et al.. (2021). Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity. eLife. 10. 26 indexed citations
6.
Levi-Galibov, Oshrat, Hagar Lavon, Meirav Pevsner‐Fischer, et al.. (2020). Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer. Nature Communications. 11(1). 6245–6245. 67 indexed citations
7.
Levi-Galibov, Oshrat, et al.. (2020). The Role of HSF1 and the Chaperone Network in the Tumor Microenvironment. Advances in experimental medicine and biology. 1243. 101–111. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026